The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Gilead Sciences Inc

Nasdaq: GILD
Last

(U.S.) $70.52

Today's change+0.04 +0.06%
Updated June 23 4:15 PM EDT. Delayed by at least 15 minutes.
 

Gilead Sciences Inc

Nasdaq: GILD
Last

(U.S.) $70.52

Today's change+0.04 +0.06%
Updated June 23 4:15 PM EDT. Delayed by at least 15 minutes.

Gilead Sciences Inc up slightly

Gilead Sciences Inc closed up just (U.S.)$0.04 Friday to (U.S.)$70.52. Over the last five days, shares have gained 9.98%, but are currently unchanged over the last year to date. Shares have underperformed the S&P 500 by 30.79% during the last year.

Key company metrics

  • Open(U.S.) $71.24
  • Previous close(U.S.) $70.48
  • High(U.S.) $71.37
  • Low(U.S.) $69.84
  • Bid / Ask(U.S.) $70.61 / (U.S.) $70.82
  • YTD % change-1.52%
  • Volume22,911,223
  • Average volume (10-day)12,613,988
  • Average volume (1-month)9,105,679
  • Average volume (3-month)8,683,913
  • 52-week range(U.S.) $63.76 to (U.S.) $88.85
  • Beta1.23
  • Trailing P/E7.45×
  • P/E 1 year forward8.45×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $2.08
  • Dividend yield2.95%
  • Trailing EPS(U.S.) $9.46
Updated June 23 4:15 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.65%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue6,5057,3207,5007,776
Total other revenue--------
Total revenue6,5057,3207,5007,776
Gross profit5,5486,2456,3716,912
Total cost of revenue9571,0751,129864
Total operating expense2,7383,2753,1013,238
Selling / general / administrative850992831890
Research & development9311,2081,1411,484
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income3,7674,0454,3994,538
Interest income (expense), net non-operating-261-265-242-227
Gain (loss) on sale of assets--------
Other--------
Income before tax3,6173,9204,2764,399
Income after tax2,6993,0993,3253,497
Income tax, total918821951902
Net income2,7023,1083,3303,497
Total adjustments to net income--------
Net income before extra. items2,7023,1083,3303,497
Minority interest3950
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items2,7023,1083,3303,497
Inc. avail. to common incl. extra. items2,7023,1083,3303,497
Diluted net income2,7023,1083,3303,497
Dilution adjustment0000
Diluted weighted average shares1,3201,3251,3391,355
Diluted EPS excluding extraordinary itemsvalue per share2.052.352.492.58
Dividends per sharevalue per share0.520.470.470.47
Diluted normalized EPSvalue per share2.052.352.492.58